論文

• Yayoi Kawata, Taisuke Ichimaru, Masakazu Kogami, Kota Kodama, Shuto Miyashita, Shintaro Sengoku. Multi-layer platform coordination for open innovation in oligonucleotide therapeutics, Drug Discovery Today, Elsevier Current Trends, Vol. 30, No. 2, Jan. 2025.  公式リンク  
  
• Hiromu Yoshiura, Yayoi Kawata, Shintaro Sengoku. Open Innovation and regulatory challenges in new modality development: the pivotal role of contract development and manufacturing organisations in advancing antibody drugs, Therapeutic Innovation & Regulatory Science, Springer International Publishing, Vol. 59, No. 1, pp. 63-70, Oct. 2024.  公式リンク  
  
• 川田 弥生, 伊波 興一朗, 梅田 佳実, 仙石 愼太郎. 技術プラットフォームに基づくバイオテック企業の価値形成モデル -ペプチドリーム社の事例-, 日本知財学会誌, 日本知財学会, Vol. 19, No. 1, pp. 58-73, Oct. 2022.  公式リンク  
  
• Yayoi Kawata, Kota Kodama, Shintaro Sengoku. Effect of external innovation on advanced pharmaceutical R&D: The case of monoclonal antibody drug development, 2022 Portland International Conference on Management of Engineering and Technology (PICMET), Proceedings of PICMET'22 Conference: Portland International Center for Management of Engineering and Technology, IEEE, Sept. 2022.  公式リンク  
  

学位論文

• Relationship between Technological Development and Open Innovation in the Pharmaceutical Industry,  Outline,  Tokyo Institute of Technology, 
• Relationship between Technological Development and Open Innovation in the Pharmaceutical Industry,  Thesis,  Tokyo Institute of Technology, 
• Relationship between Technological Development and Open Innovation in the Pharmaceutical Industry,  Summary,  Tokyo Institute of Technology, 

[ BibTeX 形式で保存 ]    [ 論文・著書をCSV形式で保存 ]    [ 特許をCSV形式で保存 ]